Boston Millennia Partners
VC Fund
Boston, United States
Boston Millennia Partners is a VC fund in Boston focused on Health Care and Biotechnology. Boston Millennia Partners (BMP) has a long and successful history of growth capital investing on a national scope. Our Core Company Investment Strategy, combined with our international network of relationships and deep industry expertise, sets us apart from other investor groups and enables us to contribute meaningfully to our portfolio companies.The company focuses on investment opportunities within the healthcare and business services industries. Outsourcing and software as a service business companies are of particular interest for investment.Boston Millennia Partners' goal is to be supportive and effective investing partners, and establish productive relationships with its business partners that create long-term value.The company seeks to partner with entrepreneurs who share our goal of building enduring, large-scale businesses that result in personal fulfillment and superior financial returns. Over the past thirty years, it has implemented an investment approach that centers on active participation with our portfolio companies. Its goal is to be supportive and effective investing partners and establish productive relationships with its business partners that create long-term value.
- Total investments:
- 120
- Last investment:
- Lead investor:
- 20%
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Boston Millennia Partners invests in
Stages Boston Millennia Partners invests in
Countries Boston Millennia Partners invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Series B
- $5M–$53M
- Series C
- $5.5M–$43M
Investment Focus
Industry
- Health Care 29 (24%)
- Biotechnology 16 (13%)
- Medical 12 (10%)
- Software 12 (10%)
- Information Technology 8 (7%)
Stage
- Funding Round 30 (25%)
- Series C 19 (16%)
- Series B 18 (15%)
- Series A 17 (14%)
- Seed 8 (7%)
Country
- United States 69 (57%)
- Israel 1 (1%)
- Hungary 1 (1%)
- Switzerland 1 (1%)
- United Kingdom 1 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Bruce Tiedemann
Partner / CFO
|
Partner / CFO | Total investments: 0 | Find email | |
Dana Callow
Managing General Partner
|
Managing General Partner | Total investments: 0 | Find email | |
Dana Callow
Managing General Partner
|
Managing General Partner | Total investments: 3 | Find email | |
Frank Silva
Principal
|
Principal | Total investments: 0 | Find email | |
Liz Callow
Associate
|
Associate | Total investments: 0 | Find email | |
| See all 11 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
BEKHealth
|
BEKHealth offers R&D platform solutions that will increase the efficiency and performance of clinical research operations. | $4M / Feb 13, 2025 | |
Korio
|
Korio is an IRT platform that focuses on industry compliance.Korio integrated the most recent IRT design intelligence into our solution to address the long-standing issues of operational inefficiencies, burdensome manual processes, and poor user experiences. | $5.5M / Series A / Sep 10, 2024 | |
S2N Health
|
S2N Health is a provider of cutting-edge strategy consulting services and SaaS solutions specifically designed for medical technology companies. Their aim is to optimize the impact and success of these companies' innovations. Since 2011, S2N Health has collaborated with over 160 companies, ranging from startups to large global organizations,providing valuable insights and analytics for crucial product, commercial, and business decisions. S2N Health offers comprehensive support throughout various stages, including development, market entry, sales acceleration, and strategic partnering. In 2022, they introduced RepSignal, an AI-driven SaaS solution that equips medtech commercial teams with on-demand customer insights and intelligence, enabling them to effectively target and engage clinical customers. | $4.3M / Seed / May 23, 2024 | |
KAID Health
|
KAID Health offers and specializes in artificial intelligence and natural language processing for healthcare organizations. KAID allows providers and payers to collaborate to achieve their individual clinical, operational, and financial goals, including revenue optimization and bending the cost-curve. | Dec 18, 2023 | |
|
Korio
|
Korio is an IRT platform that focuses on industry compliance.Korio integrated the most recent IRT design intelligence into our solution to address the long-standing issues of operational inefficiencies, burdensome manual processes, and poor user experiences. | $6.8M / Venture - Series Unknown / Oct 10, 2023 | |
QuantHealth
|
Quant Health offers drug simulation, computational biology, clinical data science, respiratory, trial simulation, and oncology services. | $15M / Series A / Aug 30, 2023 | |
Atropos Health
|
Atropos Health rapidly provides personalized real-world evidence for any clinical decision | $14M / Series A / Aug 04, 2022 | |
CubeWorks
|
CubeWorks’ mission is to accelerate the future of IoT and build a world connected by ubiquitous sensor technology through millimeter-scale smart sensing solutions. In 2013, following a decade of research on ultra-low-power circuitry at the University of Michigan, CubeWorks was founded to advance the next generation of IoT sensors. Today, with thedevelopment of the CubiSens™ Platform, CubeWorks brings to market a portfolio of ultra-small wireless smart sensors. These sensors offer limitless potential across a broad range of applications and provide access to mission-critical information exactly when and where it is needed. | $2.4M / Seed / Jun 01, 2022 | |
|
KAID Health
|
KAID Health offers and specializes in artificial intelligence and natural language processing for healthcare organizations. KAID allows providers and payers to collaborate to achieve their individual clinical, operational, and financial goals, including revenue optimization and bending the cost-curve. | $4.3M / Series A / May 24, 2022 | |
Huma.AI
|
Healthcare is extremely inefficient due to complex and disparate systems that don’t talk to each other. The explosion of data further compounds the problem. Huma.AI improves (if not solves) this inefficiency by serving as the connective tissue between system silos allowing “mere mortals” to automatically access data, gain insights and take actionusing everyday language. | $9.5M / Series A / Feb 03, 2022 | |
| See all 120 investments → | |||
Co-Investors
Excelerate Health Ventures
8 deals together
Trident Capital
8 deals together
Foundation Medical Partners
7 deals together
CMEA Ventures
6 deals together
Easton Capital
6 deals together
H.I.G. Capital
5 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Boston Millennia Partners invest in?
Boston Millennia Partners invests primarily in Health Care, Biotechnology and Medical startups, most often at Funding Round and Series C stage. Most of the 120 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Boston Millennia Partners's check size?
Boston Millennia Partners typically joins rounds of $5M–$53M at Series B and $5.5M–$43M at Series C. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Boston Millennia Partners participates in.
How do I contact Boston Millennia Partners?
Public channels for Boston Millennia Partners include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Boston Millennia Partners?
The team at Boston Millennia Partners includes Bruce Tiedemann (Partner / CFO), Dana Callow (Managing General Partner) and Dana Callow (Managing General Partner), among 11 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
